000 01342 a2200433 4500
005 20250513113854.0
264 0 _c19970417
008 199704s 0 0 eng d
022 _a0098-7484
040 _aNLM
_beng
_cNLM
100 1 _aKarpf, D B
245 0 0 _aPrevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.
_h[electronic resource]
260 _bJAMA
_cApr 1997
300 _a1159-64 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAlendronate
_xtherapeutic use
650 0 4 _aBone Density
650 0 4 _aFemale
650 0 4 _aFractures, Bone
_xprevention & control
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOsteoporosis, Postmenopausal
_xdrug therapy
650 0 4 _aProportional Hazards Models
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aShapiro, D R
700 1 _aSeeman, E
700 1 _aEnsrud, K E
700 1 _aJohnston, C C
700 1 _aAdami, S
700 1 _aHarris, S T
700 1 _aSantora, A C
700 1 _aHirsch, L J
700 1 _aOppenheimer, L
700 1 _aThompson, D
773 0 _tJAMA
_gvol. 277
_gno. 14
_gp. 1159-64
999 _c9071435
_d9071435